Literature DB >> 15030513

Induction of experimental autoimmune encephalomyelitis in Dark Agouti rats without adjuvant.

S Stosic-Grujicic1, Z Ramic, V Bumbasirevic, L Harhaji, M Mostarica-Stojkovic.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is a well-recognized model for multiple sclerosis (MS) in humans. However, adjuvants used with encephalitogens to induce EAE produce non-specific effects interfering with the mechanisms involved in the autoimmune response to the central nervous system (CNS) tissue. It is therefore important to establish a more suitable model of EAE for analysis of autoimmune phenomena resembling those operative in MS. Here we report that EAE can be induced regularly in Dark Agouti (DA) strain of rats with spinal cord tissue without any adjuvant, as judged by both clinical and histological parameters. The incidence and severity of EAE depended on the origin of the encephalitogen, the rat versus guinea pig spinal cord homogenate being more efficient. Furthermore, EAE could be reinduced in animals which had recovered from disease that had been induced actively with encephalitogen alone, suggesting the role of adjuvant-generated non-specific mechanisms in resistance to reinduction of EAE. Thus, EAE induced in DA rats with encephalitogen alone provides a reproducible model for defining pathogenically relevant events in CNS autoimmunity devoid of the potentially misleading effects of adjuvants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15030513      PMCID: PMC1808989          DOI: 10.1111/j.1365-2249.2004.02418.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  48 in total

1.  Antibody directed against mannan of the Mycobacterium tuberculosis cell envelope provokes blood-brain barrier breakdown.

Authors:  I J Namer; J Steibel
Journal:  J Neuroimmunol       Date:  2000-02-01       Impact factor: 3.478

2.  Natural adjuvants: endogenous activators of dendritic cells.

Authors:  S Gallucci; M Lolkema; P Matzinger
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

3.  Inhibitory effects of incomplete Freund's adjuvant on experimental autoimmune encephalomyelitis.

Authors:  Alex Zamora; Agata Matejuk; Marc Silverman; Arthur A Vandenbark; Halina Offner
Journal:  Autoimmunity       Date:  2002-02       Impact factor: 2.815

4.  Toll-like receptors control activation of adaptive immune responses.

Authors:  M Schnare; G M Barton; A C Holt; K Takeda; S Akira; R Medzhitov
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

5.  ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY.

Authors:  E C ALVORD; C M SHAW; S HRUBY; M W KIES
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

6.  [Prevention of allergic encephalomyelitis by prior injection of adjuvants].

Authors:  M W KIES; E C ALVORD
Journal:  Nature       Date:  1958-10-18       Impact factor: 49.962

7.  Dissection of adjuvant and suppressive effects of mycobacteria in experimental allergic encephalomyelitis production.

Authors:  M Mostarica-Stojković; S Vukmanović; M Petrović; Z Ramić; M L Lukić
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

8.  Minimum structural requirements for encephalitogen and for adjuvant in the induction of experimental allergic encephalomyelitis.

Authors:  Y Nagai; K Akiyama; K Suzuki; S Kotani; Y Watanabe; T Shimono; T Shiba; S Kusumoto; F Ikuta; S Takeda
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

9.  Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis.

Authors:  D C Lenz; N A Wolf; R H Swanborg
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

10.  Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant.

Authors:  J C Lorentzen; S Issazadeh; M Storch; M I Mustafa; H Lassman; C Linington; L Klareskog; T Olsson
Journal:  J Neuroimmunol       Date:  1995-12-31       Impact factor: 3.478

View more
  11 in total

Review 1.  CXCL12 in control of neuroinflammation.

Authors:  Miljana Momcilović; Marija Mostarica-Stojković; Djordje Miljković
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.

Authors:  Jean E Merrill; Susan Hanak; Su-Fen Pu; Jinjun Liang; Chelsea Dang; Deborah Iglesias-Bregna; Brian Harvey; Bin Zhu; Kathleen McMonagle-Strucko
Journal:  J Neurol       Date:  2009-01-24       Impact factor: 4.849

3.  Lipopolysaccharide Binding Protein and Oxidative Stress in a Multiple Sclerosis Model.

Authors:  Begoña M Escribano; Francisco J Medina-Fernández; Macarena Aguilar-Luque; Eduardo Agüera; Montserrat Feijoo; Fe I Garcia-Maceira; Rafael Lillo; Patricia Vieyra-Reyes; Ana I Giraldo; Evelio Luque; René Drucker-Colín; Isaac Túnez
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

4.  Global and 3D spatial assessment of neuroinflammation in rodent models of Multiple Sclerosis.

Authors:  Shashank Gupta; Regine Utoft; Henrik Hasseldam; Anja Schmidt-Christensen; Tine Dahlbaek Hannibal; Lisbeth Hansen; Nina Fransén-Pettersson; Noopur Agarwal-Gupta; Björn Rozell; Asa Andersson; Dan Holmberg
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

5.  Correlation of Gut Microbiota Composition with Resistance to Experimental Autoimmune Encephalomyelitis in Rats.

Authors:  Suzana Stanisavljević; Jovanka Lukić; Svetlana Soković; Sanja Mihajlovic; Marija Mostarica Stojković; Djordje Miljković; Natasa Golić
Journal:  Front Microbiol       Date:  2016-12-15       Impact factor: 5.640

6.  Oxidative damage and chemokine production dominate days before immune cell infiltration and EAE disease debut.

Authors:  Henrik Hasseldam; Rune Skovgaard Rasmussen; Flemming Fryd Johansen
Journal:  J Neuroinflammation       Date:  2016-09-15       Impact factor: 8.322

7.  Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling.

Authors:  Stefano Tambalo; Luca Peruzzotti-Jametti; Roberta Rigolio; Silvia Fiorini; Pietro Bontempi; Giulia Mallucci; Beatrice Balzarotti; Paola Marmiroli; Andrea Sbarbati; Guido Cavaletti; Stefano Pluchino; Pasquina Marzola
Journal:  J Neurosci       Date:  2015-07-08       Impact factor: 6.167

8.  Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights from macrophages.

Authors:  Taekyun Shin; Meejung Ahn; Yoh Matsumoto
Journal:  Anat Cell Biol       Date:  2012-09-30

Review 9.  Sepsis and multiple sclerosis: Causative links and outcomes.

Authors:  Đorđe Miljković; Suzana Stanisavljević; Isaac J Jensen; Thomas S Griffith; Vladimir P Badovinac
Journal:  Immunol Lett       Date:  2021-07-25       Impact factor: 4.230

10.  Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis.

Authors:  Garth E Ringheim; Lan Lee; Lynn Laws-Ricker; Tomas Delohery; Li Liu; Donghui Zhang; Nicholas Colletti; Timothy J Soos; Kendra Schroeder; Barbara Fanelli; Nian Tian; Christopher W Arendt; Deborah Iglesias-Bregna; Margaret Petty; Zhongqi Ji; George Qian; Rajula Gaur; Daniel Weinstock; Jean Cavallo; Juventas Telsinskas; Kathleen McMonagle-Strucko
Journal:  Front Neurol       Date:  2013-10-30       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.